Parsifal Capital Management »

Bio-Rad Laboratories shares owned by Parsifal Capital Management

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Parsifal Capital Management from 13F filings

Historical chart of Parsifal Capital Management investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Parsifal Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Parsifal Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $35M 129k 273.11
2024-03-31 $62M 178k 345.87
2023-12-31 $62M 192k 322.89

More positions owned by Parsifal Capital Management

Humana Call Option (HUM)
Albertsons Cos Common Stock (ACI)
Sharkninja Com Shs (SN)
Hilton Grand Vacations (HGV)
Clorox Company (CLX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
3M Company (MMM)
Atmus Filtration Technologies Ord (ATMU)
Globus Med Cl A (GMED)
International Game Technolog Shs Usd (IGT)
Core Scientific (CORZ)
Nutanix Cl A (NTNX)
Western Digital (WDC)
Cigna Corp (CI)
UnitedHealth (UNH)

View all positions for Parsifal Capital Management

Top funds holding Bio-Rad Laboratories

BlackRock
Vanguard Group
Van Eck Associates Corp.
Veritas Asset Management
First Eagle Investment Management
Select Equity
Dimensional Fund Advisors
State Street Corporation
Earnest Partners
Millennium Management
Ubs Global Asset Management Americas
Ariel Investments
Geode Capital Management
Southeastern Asset Management
Parnassus Investments

View all funds holding Bio-Rad Laboratories